405 related articles for article (PubMed ID: 26884348)
21. Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy.
Lu J; Bian ZY; Zhang R; Zhang Y; Liu C; Yan L; Zhang SM; Jiang DS; Wei X; Zhu XH; Chen M; Wang AB; Chen Y; Yang Q; Liu PP; Li H
Basic Res Cardiol; 2013 Mar; 108(2):326. PubMed ID: 23307144
[TBL] [Abstract][Full Text] [Related]
22. MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo.
Wadosky KM; Berthiaume JM; Tang W; Zungu M; Portman MA; Gerdes AM; Willis MS
J Mol Endocrinol; 2016 Apr; 56(3):273-90. PubMed ID: 26862156
[TBL] [Abstract][Full Text] [Related]
23. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
[TBL] [Abstract][Full Text] [Related]
24. TRIM32 promotes neural differentiation through retinoic acid receptor-mediated transcription.
Sato T; Okumura F; Kano S; Kondo T; Ariga T; Hatakeyama S
J Cell Sci; 2011 Oct; 124(Pt 20):3492-502. PubMed ID: 21984809
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
Yu CJ; Tang LL; Liang C; Chen X; Song SY; Ding XQ; Zhang KY; Song BL; Zhao D; Zhu XY; Li HL; Zhang ZR
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892527
[TBL] [Abstract][Full Text] [Related]
26. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
[TBL] [Abstract][Full Text] [Related]
27. Tripartite Motif-Containing Protein 32 (TRIM32): What Does It Do for Skeletal Muscle?
Jeong SY; Choi JH; Kim J; Woo JS; Lee EH
Cells; 2023 Aug; 12(16):. PubMed ID: 37626915
[TBL] [Abstract][Full Text] [Related]
28. SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload.
Wu G; Liu Y; Huang H; Tang Y; Liu W; Mei Y; Wan N; Liu X; Huang C
Cardiovasc Res; 2015 Jul; 107(2):203-15. PubMed ID: 26077624
[TBL] [Abstract][Full Text] [Related]
29. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
[TBL] [Abstract][Full Text] [Related]
30. Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy.
Deng KQ; Zhao GN; Wang Z; Fang J; Jiang Z; Gong J; Yan FJ; Zhu XY; Zhang P; She ZG; Li H
Circulation; 2018 Apr; 137(14):1486-1504. PubMed ID: 29229612
[TBL] [Abstract][Full Text] [Related]
31. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.
Yan L; Wei X; Tang QZ; Feng J; Zhang Y; Liu C; Bian ZY; Zhang LF; Chen M; Bai X; Wang AB; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H
Cardiovasc Res; 2011 Oct; 92(1):85-94. PubMed ID: 21632881
[TBL] [Abstract][Full Text] [Related]
32. Mutations that impair interaction properties of TRIM32 associated with limb-girdle muscular dystrophy 2H.
Saccone V; Palmieri M; Passamano L; Piluso G; Meroni G; Politano L; Nigro V
Hum Mutat; 2008 Feb; 29(2):240-7. PubMed ID: 17994549
[TBL] [Abstract][Full Text] [Related]
33. SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1-Dependent Manner.
Qian Q; Hu F; Yu W; Leng D; Li Y; Shi H; Deng D; Ding K; Liang C; Liu J
J Am Heart Assoc; 2023 Apr; 12(7):e028628. PubMed ID: 36974751
[TBL] [Abstract][Full Text] [Related]
34. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of TRIM32 Protects Hippocampal Neurons from Oxygen-Glucose Deprivation-Induced Injury.
Wei L; Zhang JS; Ji SF; Xu H; Zhao ZH; Zhang L; Pang L; Zhang JF; Yang PB; Ma H
Neurochem Res; 2019 Sep; 44(9):2182-2189. PubMed ID: 31410708
[TBL] [Abstract][Full Text] [Related]
36. ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK - AKT Signaling.
Xiang M; Luo H; Wu J; Ren L; Ding X; Wu C; Chen J; Chen S; Zhang H; Yu L; Zou Y; Xu H; Ye P; Chen M; Xia J
J Am Heart Assoc; 2018 Sep; 7(18):e008604. PubMed ID: 30371220
[TBL] [Abstract][Full Text] [Related]
37. STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy.
Li PL; Liu H; Chen GP; Li L; Shi HJ; Nie HY; Liu Z; Hu YF; Yang J; Zhang P; Zhang XJ; She ZG; Li H; Huang Z; Zhu L
Hypertension; 2020 Oct; 76(4):1219-1230. PubMed ID: 32862709
[TBL] [Abstract][Full Text] [Related]
38. Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
Yin H; Li Z; Chen J; Hu X
J Cell Biochem; 2019 Apr; 120(4):5232-5243. PubMed ID: 30378152
[TBL] [Abstract][Full Text] [Related]
39. Roles of TRIM32 in Corneal Epithelial Cells After Infection with Herpes Simplex Virus.
Cui H; Liu Y; Huang Y
Cell Physiol Biochem; 2017; 43(2):801-811. PubMed ID: 28954259
[TBL] [Abstract][Full Text] [Related]
40. TRIM32 is an E3 ubiquitin ligase for dysbindin.
Locke M; Tinsley CL; Benson MA; Blake DJ
Hum Mol Genet; 2009 Jul; 18(13):2344-58. PubMed ID: 19349376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
